PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PeptiDream Inc (4587) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8231
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produce peptide libraries for the identification of highly potent and selective hit candidates. Its technologies include flexizyme; translation, cyclization, and peptide modifying technologies; and PD display. PeptiDream’s technologies enables the production of peptide libraries for the development of peptide-based products. PeptiDreamoffers products for the treatment of Alzheimer’s disease, amyotrophic lateral sclerosis, and others. The company collaborates with other biotechnology and drug development companies to receive contracts and research and development support funds, and target proteins. It also has its presence in Tokyo, Japan. PeptiDream is headquartered in Kawasaki, Japan.

PeptiDream Inc (4587) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PeptiDream Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12
Venture Financing 13
Modulus Discovery Raises USD7.2 Million in Series A Financing 13
Private Equity 14
Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 14
Partnerships 15
PeptiDream Enters into Co-Development Agreement with Santen Pharma 15
Bayer and PeptiDream Enter into Partnership 16
PeptiDream and Kleo Pharma Enter into Co-Development Agreement 17
Heptares Therapeutics and PeptiDream Enter into Agreement 18
Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 19
PeptiDream Enters into Agreement with Janssen Pharma 20
PeptiDream Enters into Research Agreement with BIND Therapeutics 21
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 22
PeptiDream Enters into Agreement with Genentech 23
Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 24
Teijin Pharma Enters into Discovery Agreement with PeptiDream 25
PeptiDream Enters into Discovery Agreement with Sanofi 26
PeptiDream Enters into Peptide Discovery Agreement with Merck 27
PeptiDream Expands Drug Discovery Agreement with Novartis 28
PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 29
PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 30
PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 31
PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 32
PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 33
PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 34
Licensing Agreements 35
Eli Lilly Enters into Licensing Agreement with PeptiDream 35
Shionogi Enters into Licensing Agreement with PeptiDream 36
PeptiDream Enters Into Licensing Agreement With Eli Lilly 37
Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38
PeptiDream Exercises Option for Licensing Agreement with Novartis 39
PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40
PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41
Equity Offering 42
PeptiDream Raises USD53 Million in IPO 42
PeptiDream Inc – Key Competitors 43
PeptiDream Inc – Key Employees 44
PeptiDream Inc – Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Recent Developments 46
Corporate Communications 46
Aug 22, 2017: PeptiDream Appoints Representative Directors 46
Government and Public Interest 47
Nov 09, 2017: PeptiDream Receives Grant to Discover and Develop Novel Therapeutics for Infectious Disease 47
Product News 48
Sep 25, 2017: PeptiDream and Kawasaki Medical School Announce Novel Muscle Atrophy Inhibitor for the Treatment of Duchenne Muscular Dystrophy 48
Other Significant Developments 49
Nov 13, 2017: PeptiDream Announces 2 nd Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck & Co., Inc., Kenilworth, N.J., U.S.A 49
Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck 50
Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Kyorin 51
May 31, 2017: PeptiDream Announces 5 th Milestone from Macrocyclic Peptide Drug Discovery Alliance with Bristol-Myers Squibb 52
Mar 22, 2017: PeptiDream Announces 1st Milestone from Macrocyclic Peptide Drug Discovery Alliance with Shionogi 53
Feb 14, 2017: PeptiDream Announces the Selection of Development Candidate from Discovery Collaboration with Daiichi Sankyo 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
PeptiDream Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PeptiDream Inc, Deals By Therapy Area, 2012 to YTD 2018 9
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12
Modulus Discovery Raises USD7.2 Million in Series A Financing 13
Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 14
PeptiDream Enters into Co-Development Agreement with Santen Pharma 15
Bayer and PeptiDream Enter into Partnership 16
PeptiDream and Kleo Pharma Enter into Co-Development Agreement 17
Heptares Therapeutics and PeptiDream Enter into Agreement 18
Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 19
PeptiDream Enters into Agreement with Janssen Pharma 20
PeptiDream Enters into Research Agreement with BIND Therapeutics 21
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 22
PeptiDream Enters into Agreement with Genentech 23
Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 24
Teijin Pharma Enters into Discovery Agreement with PeptiDream 25
PeptiDream Enters into Discovery Agreement with Sanofi 26
PeptiDream Enters into Peptide Discovery Agreement with Merck 27
PeptiDream Expands Drug Discovery Agreement with Novartis 28
PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 29
PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 30
PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 31
PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 32
PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 33
PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 34
Eli Lilly Enters into Licensing Agreement with PeptiDream 35
Shionogi Enters into Licensing Agreement with PeptiDream 36
PeptiDream Enters Into Licensing Agreement With Eli Lilly 37
Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38
PeptiDream Exercises Option for Licensing Agreement with Novartis 39
PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40
PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41
PeptiDream Raises USD53 Million in IPO 42
PeptiDream Inc, Key Competitors 43
PeptiDream Inc, Key Employees 44
PeptiDream Inc, Other Locations 45

List of Figures
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Teijin Limited:企業のM&A・事業提携・投資動向
    Teijin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teijin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Isetan Mitsukoshi Holdings Ltd (3099):企業の財務・戦略的SWOT分析
    Isetan Mitsukoshi Holdings Ltd (3099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Owens Corning (OC):企業の財務・戦略的SWOT分析
    Owens Corning (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aerocon Engineering Company:企業の戦略・SWOT・財務情報
    Aerocon Engineering Company - Strategy, SWOT and Corporate Finance Report Summary Aerocon Engineering Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cameco Corporation:企業のM&A・事業提携・投資動向
    Cameco Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cameco Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務情報
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bechtel Corp:企業の戦略的SWOT分析
    Bechtel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Keystone Foods LLC:企業の戦略・SWOT・財務情報
    Keystone Foods LLC - Strategy, SWOT and Corporate Finance Report Summary Keystone Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • China Construction Bank Corp
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aprima Medical Software Inc-医療機器分野:企業M&A・提携分析
    Summary Aprima Medical Software Inc (Aprima) is an information technology service provider for pharmaceutical sector. The company’s solutions include EHR, practice management, and revenue cycle management. Its EHR solutions provide patient engagement, mobility, clinical decision support, integrated …
  • Intellipharmaceutics International Inc (IPCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosa …
  • Knight-Swift Transportation Holdings Inc. (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc. (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Mediq NV:企業の戦略的SWOT分析
    Mediq NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • ABC arbitrage SA (ABCA):企業の財務・戦略的SWOT分析
    ABC arbitrage SA (ABCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of alle …
  • Aramex (ARMX):企業の財務・戦略的SWOT分析
    Summary Aramex, formerly Arab International Logistics (Aramex) Co PJSC is a transport and logistics service provider that offers supply chain solutions. The company offers solutions such as e-commerce, logistics, small business solutions, developers solutions center, drop and ship, shop and ship, am …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆